/INSD

INSD Stock - Instadose Pharma Corp.

Q: What is the analyst price target for INSD?

Analyst price target information is not currently available for INSD.

Q: What is INSD's market cap?

Market capitalization information is not currently available for INSD.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for INSD

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2017

FY2018

FY2019

FY2020

FY2021

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-401.63

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2021	FY2020	FY2019	FY2018	FY2017
Revenue	N/A	N/A	N/A	$3,604.868	N/A
Gross Profit	N/A	N/A	N/A	$1,771.232	N/A
Gross Margin	N/A	N/A	N/A	49.1%	N/A
Operating Income	$-462,023	$-25,657	$-23,273	$-23,540	$-31,947
Net Income	$-589,000	$-33,313	$-38,581	$-31,255.47	$-41,112.594
Net Margin	N/A	N/A	N/A	-867.0%	N/A
EPS	$-0.00	$-0.00	$-0.00	$-0.00	$-0.00

Company Overview

Instadose Pharma Corp. engages in growing, cultivation, processing, and global distribution of medical-grade cannabinoid oil. The company was founded in 2017 and is based in Burlington, Canada.

Visit Website

Earnings History & Surprises

INSD

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$-0.00

Q1 2022

EPS Surprise History

Q2 19

No data

Q3 19

No data

Q1 20

No data

Q2 20

No data

Q3 20

No data

Q2 21

No data

Q3 21

No data

Q1 22

No data

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q1 2022	Feb 28, 2022	—	$-0.00	—	—
Q3 2021	Aug 31, 2021	—	$-0.00	—	—
Q2 2021	May 31, 2021	—	$-0.00	—	—
Q3 2020	Aug 31, 2020	—	$-0.00	—	—
Q2 2020	May 31, 2020	—	$-0.00	—	—
Q1 2020	Feb 29, 2020	—	$-0.00	—	—
Q3 2019	Aug 31, 2019	—	$-0.00	—	—
Q2 2019	May 31, 2019	—	$-0.00	—	—
Q1 2019	Feb 28, 2019	—	$-0.00	—	—
Q3 2018	Aug 31, 2018	—	$-0.00	—	—
Q2 2018	May 31, 2018	—	$-0.00	—	—
Q1 2018	Feb 28, 2018	—	$-0.00	—	—
Q3 2017	Aug 31, 2017	—	$-0.00	—	—
Q1 2017	Feb 28, 2017	—	$-0.00	—	—

Frequently Asked Questions about INSD

What is INSD's current stock price?

Instadose Pharma Corp. (INSD) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for INSD?

No analyst price targets are currently available for this stock.

What sector is Instadose Pharma Corp. in?

Instadose Pharma Corp. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is INSD's market cap?

Instadose Pharma Corp. has a market capitalization of $0.00 billion, making it a small-cap company.

Does INSD pay dividends?

No, Instadose Pharma Corp. does not currently pay a dividend to shareholders.